Proteasome inhibition and its therapeutic potential in multiple myeloma
about
The Role of Panobinostat Plus Bortezomib and Dexamethasone in Treating Relapsed or Relapsed and Refractory Multiple Myeloma: A European PerspectiveTrial Watch: Proteasomal inhibitors for anticancer therapyPrimary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.JNK and macroautophagy activation by bortezomib has a pro-survival effect in primary effusion lymphoma cells.Identification of agents that promote endoplasmic reticulum stress using an assay that monitors luciferase secretion.Ultraviolet activation of PKD: implications for skin cancer.Proteasome inhibitors mechanism; source for design of newer therapeutic agents.Therapeutic targeting of cancer cell cycle using proteasome inhibitorsSulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways.Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity.
P2860
Q28069789-3D122CC7-223C-4B28-9D07-1E104F93ACF7Q28082910-675F6F42-A051-4F6B-B6B8-A290A24A2680Q28481417-30140667-7F27-47A5-876F-476034785270Q34195083-1FF6986E-0831-4502-9903-97B4E681470EQ35006105-2F72AB13-CC81-4F85-AE2E-4CDB2345B050Q35076504-4E6CD5CB-BC09-44C2-B48C-28466AE1F072Q37094286-8FA7EC7F-58C0-4BD8-BF1B-D2EFA48A28FCQ38003334-2A10B701-A54F-43F8-BCCE-68A46F589BB4Q38069898-7ECC5B41-4A7D-4F22-8843-1839AECB0CB5Q38676278-7C6648A2-624F-461D-BF4E-D738980F110EQ41363502-1EB82D15-F4F5-4FDE-A8A8-325CD778F723
P2860
Proteasome inhibition and its therapeutic potential in multiple myeloma
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Proteasome inhibition and its therapeutic potential in multiple myeloma
@ast
Proteasome inhibition and its therapeutic potential in multiple myeloma
@en
Proteasome inhibition and its therapeutic potential in multiple myeloma
@nl
type
label
Proteasome inhibition and its therapeutic potential in multiple myeloma
@ast
Proteasome inhibition and its therapeutic potential in multiple myeloma
@en
Proteasome inhibition and its therapeutic potential in multiple myeloma
@nl
prefLabel
Proteasome inhibition and its therapeutic potential in multiple myeloma
@ast
Proteasome inhibition and its therapeutic potential in multiple myeloma
@en
Proteasome inhibition and its therapeutic potential in multiple myeloma
@nl
P2093
P2860
P356
P1476
Proteasome inhibition and its therapeutic potential in multiple myeloma
@en
P2093
Ajai Chari
Amitabha Mazumder
Sundar Jagannath
P2860
P304
P356
10.2147/BTT.S3419
P577
2010-09-28T00:00:00Z